ריוואסטיגמין אינובמד 1.5 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

RIVASTIGMINE AS HYDROGEN TARTRATE 1.5 MG

MAH:

INOVAMED LTD

ATC_code:

N06DA03

pharmaceutical_form:

CAPSULES

administration_route:

PER OS

manufactured_by:

ACTAVIS GROUP PTC ehf, ICELAND

therapeutic_group:

RIVASTIGMINE

therapeutic_indication:

Symptomatic treatment of mild to moderately severe Alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementia associated with Parkinson's disease.

authorization_date:

2013-04-01